WNT3A and renal cell carcinoma: Protein expression levels of Wnt3a and FZD1 were down-regulated in A498/R (Figure 5), suggesting that PDIA6 contributed to the activation of Wnt3a-FZD1 pathway in imatinib-resistant renal cell carcinoma.